Cooper Surgical Blastomere Biopsy Micropipets

Country: Singapor

Lingwa: Ingliż

Sors: HSA (Health Sciences Authority)

Disponibbli minn:

NEUVITAL PTE. LTD.

Klassi:

Class B medical device

Manifatturat minn:

Cooper Surgical Inc

Żona terapewtika:

Obstetrics & Gynaecology

Indikazzjonijiet terapewtiċi:

Blastomere Biopsy micropipets are used to remove a blastomere cell from a blastocyst to perform pre-implantation genetic diagnosis.

Sommarju tal-prodott:

Models: Blastomere Biopsy Pipets - MBB-FP-SM-0, Blastomere Biopsy Pipets - MBB-FP-SM-20, Blastomere Biopsy Pipets - MBB-FP-SM-25, Blastomere Biopsy Pipets - MBB-FP-SM-30, Blastomere Biopsy Pipets - MBB-FP-SM-35, Blastomere Biopsy Pipets - MBB-FP-SM-40, Blastomere Biopsy Pipets - MBB-FP-SM-45, Blastomere Biopsy Pipets - MBB-BP-SM-0, Blastomere Biopsy Pipets - MBB-BP-SM-20, Blastomere Biopsy Pipets - MBB-BP-SM-25, Blastomere Biopsy Pipets - MBB-BP-SM-30, Blastomere Biopsy Pipets - MBB-BP-SM-35, Blastomere Biopsy Pipets - MBB-BP-SM-45, Blastomere Biopsy Pipets - MBB-FP-M-0, Blastomere Biopsy Pipets - MBB-FP-M-20, Blastomere Biopsy Pipets - MBB-FP-M-25, Blastomere Biopsy Pipets - MBB-FP-M-30, Blastomere Biopsy Pipets - MBB-FP-M-35, Blastomere Biopsy Pipets - MBB-FP-M-45, Blastomere Biopsy Pipets - MBB-BP-M-0, Blastomere Biopsy Pipets - MBB-BP-M-20, Blastomere Biopsy Pipets - MBB-BP-M-25, Blastomere Biopsy Pipets - MBB-BP-M-30, Blastomere Biopsy Pipets - MBB-BP-M-35, Blastomere Biopsy Pipets - MBB-FP-L-0, Blastomere Biopsy Pipets - MBB-FP-L-15, Blastomere Biopsy Pipets - MBB-FP-L-20, Blastomere Biopsy Pipets - MBB-FP-L-25, Blastomere Biopsy Pipets - MBB-FP-L-30, Blastomere Biopsy Pipets - MBB-FP-L-35, Blastomere Biopsy Pipets - MBB-BP-L-0, Blastomere Biopsy Pipets - MBB-BP-L-30, Blastomere Biopsy Pipets - MBB-BP-L-35, Blastomere Biopsy Pipets - MBB-FP-XS-25, Blastomere Biopsy Pipets - MBB-FP-XS-30, Blastomere Biopsy Pipets - MBB-FP-XS-35, Blastomere Biopsy Pipets - MBB-FP-XXS-25, Blastomere Biopsy Pipets - MBB-FP-XXS-30, Blastomere Biopsy Pipets - MBB-FP-XXS-35

Data ta 'l-awtorizzazzjoni:

2019-01-18